These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 26759826

  • 1. Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
    Basu A, Jenkins AJ, Zhang Y, Stoner JA, Klein RL, Lopes-Virella MF, Timothy Garvey W, Lyons TJ, DCCT/EDIC Research Group.
    Data Brief; 2016 Mar; 6():33-8. PubMed ID: 26759826
    [Abstract] [Full Text] [Related]

  • 2. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
    Lyons TJ, Jenkins AJ, Zheng D, Klein RL, Otvos JD, Yu Y, Lackland DT, McGee D, McHenry MB, Lopes-Virella M, Garvey WT, DCCT/EDIC Research Group.
    Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Diabetes; 1999 Feb; 48(2):383-90. PubMed ID: 10334318
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.
    Lyons TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, Garvey WT, Klein RL.
    Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):910-8. PubMed ID: 14985310
    [Abstract] [Full Text] [Related]

  • 7. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
    Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL, DCCT/EDIC Research Group.
    Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
    [Abstract] [Full Text] [Related]

  • 8. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
    Purnell JQ, Zinman B, Brunzell JD, DCCT/EDIC Research Group.
    Circulation; 2013 Jan 15; 127(2):180-7. PubMed ID: 23212717
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes.
    Lopes-Virella MF, McHenry MB, Lipsitz S, Yim E, Wilson PF, Lackland DT, Lyons T, Jenkins AJ, Virella G, DCCT/EDIC Research Group.
    Atherosclerosis; 2007 Feb 15; 190(2):359-69. PubMed ID: 16530770
    [Abstract] [Full Text] [Related]

  • 13. RISK FACTORS FOR HEARING IMPAIRMENT IN TYPE 1 DIABETES.
    Braffett BH, Lorenzi GM, Cowie CC, Gao X, Bainbridge KE, Cruickshanks KJ, Kramer JR, Gubitosi-Klug RA, Larkin ME, Barnie A, Lachin JM, Schade DS, DCCT/EDIC Research Group.
    Endocr Pract; 2019 Dec 15; 25(12):1243-1254. PubMed ID: 31412233
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D.
    Basu A, Jenkins AJ, Stoner JA, Zhang Y, Klein RL, Lopes-Virella MF, Garvey WT, Schade DS, Wood J, Alaupovic P, Lyons TJ, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.
    J Lipid Res; 2018 May 15; 59(5):872-883. PubMed ID: 29576550
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.
    Lopes-Virella MF, Hunt KJ, Baker NL, Lachin J, Nathan DM, Virella G, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.
    Diabetes; 2011 Feb 15; 60(2):582-9. PubMed ID: 20980456
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lipids and lipoprotein ratios: contribution to carotid intima media thickness in adolescents and young adults with type 2 diabetes mellitus.
    Shah AS, Urbina EM, Khoury PR, Kimball TR, Dolan LM.
    J Clin Lipidol; 2013 Feb 15; 7(5):441-5. PubMed ID: 24079285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.